The European Patent Office (EPO) has officially granted and published patent EP3465203B1, detailing methods of immunotherapy. The patent lists inventors Rajiv Khanna and Corey Smith and was published on March 18, 2026. This grant signifies the EPO's recognition of novel advancements in the field of immunotherapy, contributing to the public record of intellectual property.

This publication is primarily an informational notice regarding a granted patent. For entities involved in the pharmaceutical or biotechnology sectors, particularly those developing or researching immunotherapies, this patent may represent a new piece of intellectual property landscape. While it does not impose new compliance obligations, it is crucial for R&D, legal, and competitive intelligence teams to be aware of granted patents in their field to understand existing IP rights and potential licensing or infringement considerations.